US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
    US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
    12 September 2023, Geneva/New York – Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Natio...
    病者有其药项目
    结核病 (TB)
    Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
    India
    Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
    Recent deal offering controlled generics access in limited countries does not go far enough.
    结核病 (TB)
    病者有其药项目
    Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
    Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
    Doctors Without Borders /Médecins Sans Frontières(MSF) called on governments and donors today to speed up access to new, shorter, safer and more effec...
    病者有其药项目
    结核病 (TB)
    HIV/AIDS in the DRC: Behind the progress, huge challenges remain
    DR Congo
    HIV/AIDS in the DRC: Behind the progress, huge challenges remain
    In 2002, Doctors Without Borders / Médecins Sans Frontières (MSF) teams opened the first outpatient treatment centre offering free care to people livi...
    HIV/爱滋病
    病者有其药项目
    Belarus: Three hundred patients start innovative TB treatment programme
    Belarus
    Belarus: Three hundred patients start innovative TB treatment programme
    “On the tenth day of my treatment, I could tell that something was wrong with my ears,” says Maria. “The drugs were affecting my auditory nerve. Havin...
    结核病 (TB)
    病者有其药项目
    传染病
    Doctors Without Borders and its partners’ TB PRACTECAL Clinical Trial will be included in the updated WHO global guidance on treatment
    Doctors Without Borders and its partners’ TB PRACTECAL Clinical Trial will be included in the updated WHO global guidance on treatment
    Geneva, 3 May2022 - Doctors Without Borders / Médecins Sans Frontières (MSF) are pleased that,having shared the results of TBPRACTECAL, our clinical t...
    病者有其药项目
    结核病 (TB)
    Northern Syria: Ineffective COVID-19 vaccine system has hampered vaccination
    Syria
    Northern Syria: Ineffective COVID-19 vaccine system has hampered vaccination
    The COVID-19 vaccine Humanitarian Buffer (HB) is failing its mission to support populations hit by the pandemic and struggling to have access to immun...
    病者有其药项目
    新冠疫苗
    Malaysia: Safe and affordable healthcare for all essential in health system reform
    Malaysia
    Malaysia: Safe and affordable healthcare for all essential in health system reform
    Doctors Without Borders / Medecins Sans Frontieres (MSF) welcomes Health Minister Khairy Jamaluddin’s proposal to reform the country’s health system a...
    难民
    病者有其药项目
    Doctors Without Borders response to license between Pfizer and Medicines Patent Pool for new COVID-19 treatment Paxlovid
    Doctors Without Borders response to license between Pfizer and Medicines Patent Pool for new COVID-19 treatment Paxlovid
    Pfizer recently shared positive interim results for its COVID-19 oral antiviral investigational candidate PF-07321332 in combination with ritonavir (P...
    病者有其药项目
    订阅最新资讯
    © Doctors Without Borders
    Privacy Policy